Rheumatoid Arthritis Medicine
Our range of products include baricitinib olumiant 4mg tablet, hyaluronic acid hyalgan injection 20 mg and exemptia adalimumab 40 mg injection.
Baricitinib Olumiant 4mg Tablet
Approx. Price: Rs 8,070 / BoxGet Latest Price Product Details:
| Strength | 4 mg |
| Brand | Olumiant |
| Form | Film Coated Tablet |
| Packaging Size | 4 tablets |
| Usage | Rheumatoid Arthritis |
| compostion | Baricitinib |
Olumiant 4mg Tablet is used to treat moderate to severe rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage.
Hyaluronic Acid Hyalgan Injection 20 mg
Approx. Price: Rs 1,800 / VialGet Latest Price Product Details:
| Molecular Weight | Intermediate MW |
| Injection Type | Single Injection |
| Hyaluronic Acid Strength | 20 mg/2 ml |
| Brand | Hyalgan |
| Syringe Volume | 2 ml |
| Target Joint | Knee |
| Storage Temp | Room Temperature |
Hyalgan Injection is a medicine used in the treatment of osteoarthritis of the knee in patients who have failed to respond adequately to conservative therapy and simple analgesics. It reduces the swelling and stiffness in the joints and improve joint function.
Exemptia Adalimumab 40 mg injection
Approx. Price: Rs 8,000 / VialGet Latest Price Product Details:
| Brand | Exemptia |
| Strength | 40 mg |
| Delivery Form | Pre Filled Syringe |
| Strength Per ml | 40 mg/0.8 ml |
| Usage | Rheumatoid Arthritis |
| Packaging Size | 1 pre filled syringe |
| Storage Temp | 2–8°C |
Adalimumab is a monoclonal antibody that targets tumor necrosis factor (TNF-alpha) and is used to support management of autoimmune and inflammatory conditions; Exemptia® is a branded adalimumab formulation manufactured using advanced biologic technology to ensure consistent quality, safety, and therapeutic performance
